Acute Heart Failure - Drug Pipeline Analysis and Market Forecasts to 2016

Oct. 13, 2010 - PRLog -- GlobalData, the industry analysis specialist's new report, "Acute Heart Failure-Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global acute heart failure market. The report identifies the key trends shaping and driving the global acute heart failure market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global acute heart failure sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope
The scope of the report includes:
-Annualized global acute heart failure market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
-Geographic markets covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
-Analysis of the current and future market competition in the global acute heart failure market.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with acute heart failure.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global acute heart failure market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global acute heart failure market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global acute heart failure market landscape? -Identify, understand and capitalize.



Table of Contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Acute Heart Failure: Market Characterization 5
2.1 Overview 5
2.2 Acute Heart Failure Market Size 5
2.3 Acute Heart Failure Market Forecast and CAGR 6
2.4 Drivers and Barriers for the AHF Market 8
2.4.1 Drivers of the Acute Heart Failure Market 8
2.4.2 Barriers for the Acute Heart Failure Market 8
2.5 Opportunity and Unmet Need 9
2.6 Key Takeaway 10
3 Acute Heart Failure Market: Competitive Assessment 11
3.1 Overview 11
3.2 Strategic Competitor Assessment 11
3.3 Product Profile for the Major Marketed Products in the Acute Heart Failure Market 12
3.3.1 Natrecor (Nesiritide) 12
3.3.2 Primacor (Milrinone Lactate) 12
3.3.3 Coreg (Carvedilol) 13
3.3.4 Altace (Ramipril) 14
3.3.5 Atacand (Candesartan) 15
3.3.6 Bidil (Isosorbide Dinitrate and Hydralazine Hydrochloride) 16
3.4 Key Takeaway 17
4 Acute Heart Failure: Pipeline Assessment 18
4.1 Overview 18
4.2 Strategic Pipeline Assessment 18
4.2.1 Technology Trends Analytic Framework 18
4.3 Acute Heart Failure Therapeutics-Promising Drugs under Clinical Development 19
4.4 Drugs under Clinical Development 20
4.4.1 Tekturna/Rasilez 20
4.4.2 Lixivaptan 20
4.4.3 Relaxin 21
4.4.4 Cinaciguat 22
4.5 Acute Heart Failure Therapeutics Market-Clinical Pipeline by Mechanism of Action 22
4.6 Acute Heart Failure Pipeline-Pipeline by Clinical Phases of Development 23
4.6.1 Acute Heart Failure Therapeutics-Phase III Clinical Pipeline 23
4.6.2 Acute Heart Failure Therapeutics-Phase II Clinical Pipeline 24
4.6.3 Acute Heart Failure Therapeutics-Phase I Clinical Pipeline 24
4.7 Discontinued/Suspended Drugs for Acute Heart Failure 24
4.8 Key Takeaway 24
5 Acute Heart Failure Market: Implications for Future Market Competition 25
6 Acute Heart Failure Market: Future Players in the Acute Heart Failure Market 26
6.1 Introduction 26

......

# # #

ChinaCCM.com is China's leading industry consultancy expert offering industry intelligence and research solution, ChinaCCM Market Research Centre is a research division focusing on professional market survey and industry research.